Sarcoma Study Details

Reference

NCT02484443

 Short title

A Phase II Study of Human-Mouse Chimeric Anti-Disialoganglioside Monoclonal Antibody ch14.18 (Dinutuximab, NSC# 764038, IND# 4308) in Combination with Sargramostim (GM-CSF) in Patients with Recurrent Osteosarcoma


Australian Sites

John Hunter Hospital, Sydney Children's Hospital, The Children's Hospital at Westmead
Lady Cilento Children's Hospital, Women's and Childrens' Hospital-Adelaide
Royal Children's Hospital, Monash Medical Centre-Clayton Campus


 Open
2015
Contacts

SA - Maria L Kirby cywhs.oncsec@health.sa.gov.au;
VIC - Francoise Mechinaud crdo.info@mcri.edu.au


 Go back to Sarcoma Studies